Company Report | Showing Brilliant Performance

MYOR recorded 1Q23 revenue growth of 11.4% YoY to IDR 8.5 trillion, led by the Packaged Food Processing segment, which grew 11.8% YoY. The brilliant performance was reflected in 1Q23 net profit, which also experienced significant growth of 137.6% YoY to IDR 727.2 billion.

Company Report | High Raw Material Costs Still Weighing on Performance

In 1Q23, CPIN managed to record sales growth of 1.9% YoY to IDR 14.6 trillion (vs. 1Q22: IDR 14.3 trillion). The increase in raw material costs happened due to higher Soybean Meal (SBM) and Corn prices, by 3.5% YoY, which caused the cost of sales to increase by 10.0% YoY in 1Q23 and made gross profit contracted by 38.4% YoY to IDR 1.5 trillion.

Company Report | Solid Performance in 1Q23

MAPI began 1Q23 with a solid performance, reflected in sales that grew 32.5% YoY to IDR 7.5 trillion. The Retail Sales segment led the 1Q23 sales growth of 38.7% YoY.

Company Report | Actively Developing Non-Smartphone Business

ERAA managed to record sales growth in 1Q23 of 28.9% YoY, led by the Accessories and others segment, which rose 42.1% YoY. The company also recorded a net profit decline of 20.2% YoY. By business vertical, Erajaya Digital still contributed the most at 92.1%.

Company Report | Unrealized Forex Gains Bring 1Q23 Net Profit to Significant Growth

CBP started 1Q23 by recording sales growth of 11.4% YoY, buoyed by both domestic and overseas sales, as well as higher volume and average selling price (ASP). Meanwhile, unrealized forex gains arising from financing activities caused 1Q23 net profit to grow significantly by 103.7% YoY to Rp4.0 trillion. This led to a higher NPM of 20.7% in 1Q23.

Company Report | Moderate Growth in 2023

In 1Q23, SIDO managed to book growth on the Top and Bottom Lines. Sales grew 3% YoY, led by the Food and Beverage segment, which increased 7% YoY. Net profit recorded a 2% YoY increase, bringing NPM to a higher number than the previous quarter at 33% (vs 4Q22: 31%).

Company Report | All Segments Deliver Solid Performance 4Q22

KLBF recorded 4Q22 sales of IDR 7.8 trillion, and cumulative FY22 sales grew 10.2% YoY to IDR 28.9 trillion, led by the Consumer Health segment. Net profit for 4Q22 was recorded at IDR 896.7 billion, and cumulative FY22 sales grew 6.2% YoY to IDR 3.4 trillion.